Seal oil is an excellent source of Omega-3 fatty acids. Omega-3’s are a special type of long-chain fatty acids, a pure unsaturated fatty acid (PUFA) which is known as “good-healthy fat”. Seal oil contains high levels of EPA (Eicosapentaenoic acid), DHA (Docosahexaenoic acid) and up to ten times the level of DPA (Docosapentaenoic acid) found in fish oils.
These essential fatty acids have been bio-filtered by the seal and are easily absorbed and metabolized by the human body. Nutritionists and physicians recommend a daily intake of Omega-3 fatty acids as part of a healthy diet. The recommended minimum average consumption of Omega-3 fatty acids in North America and Europe is about 250mg to 500mg. Supplementing our diets with 2 capsules of 500mg per day can make up for this deficiency. Clinical studies conducted over the past 20 years continue to link Omega-3’s with improved general health, preventative care, and overall maintenance.
The Superiority of Harp Seal Oil
Omega-3 Seal Oil that is made in Canada from pure Harp Seal oil, is nature’s ideal blend of EPA, DHA & DPA. Omega-3 Seal Oil offers superior properties, easier digestibility, and better assimilation than other Omega-3 sources. Laboratory analysis that compares the quality of Omega-3 with other Omega-3 products has found that Omega-3 Seal Oil provides substantially higher levels of EPA, DPA, and DHA than those that use other sources such as fish or flaxseed oil.
Omega-3 Seal Oil offers the following health benefits
1. Excellent source of the most important essential fatty acids: EPA, DHA and DPA. Essential fatty acids play a vital role in maintaining the integrity and fluidity of the membrane that surrounds human cells by protecting the cell from damages caused by free radicals or the process of oxidation within the body as well as loss of receptivity to hormones and their ability to relay chemically encoded instructions for cellular repair.
2. Superior source of Omega-3 fatty acids, compared to flaxseed and fish oils: The body’s absorption of Omega-3 from seal blubber is faster and more thorough than is the case with flaxseed and fish oils, due to the molecular configurations of the EPA and DHA in seal oil. Seal oil includes a high level of DPA (up to ten times that of fish oils). Evidence suggests that DPA is the most important of the essential fatty acids in keeping artery walls soft and plaque free. It is more stable than fish oil and less vulnerable to the natural process of oxidation.
3. Flaxseed oil contains no EPA, DHA or DPA, rather it contains linolenic acid which is a building block that enables healthy people to manufacture EPA. Evidence indicates that the rate of metabolic conversion can be slow and unsteady, particularly among those with impaired health. Fish oils vary considerably in the type and level of fatty acid composition depending on the particular species and their diets. Aquaculture raised fish tend to have lower levels of Omega-3 fatty acids than those in the wild. Research has shown that seal oil is not very beneficial to those at risk of heart disease and diabetes.
Side Effects in Fish Oil >>
DPA on the Rise
Numerous studies indicate insufficient levels of docosapentaenoic acid (DPA) in diets and blood circulation may serve as a predictor and indicator of broad range of health conditions, and may also be a distinct and powerful nutritional and therapeutic supplement.
The health benefits of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) fatty acids are among the most documented in nutrition research. However, a third key fatty acid, docosapentaenoic acid (DPA)an intermediary between EPA and DHA, has been shown to play a powerful role in key health outcomes. DPA, an elongated version of EPA, has drawn the attention of scientists because it is present in relatively high levels in the diet of Greenland Inuits, a population with exceptionally low incidence of cardiovascular disease (CVD).
Generally, Americans do not consume Inuit dietary stapleswhale and seal meat and blubber. However, USDA National Nutrient Database indicates DPA is present in marine oils, with menhaden oil documented as the richest fish oil source of the compound. In the last three decades, scientific studies focused on oils that contained mixtures of fatty acids, or on purified EPA and DHA, while the amount of research focused on DPA was limited. Nevertheless, a careful review of the published literature indicates inadequate dietary intake and low circulating blood levels of DPA may serve as a predictor and indicator of a broad range of diseases.
Among the many health conditions DPA addresses, heart health has received considerable scientific attention. A recent Harvard study, which involved more than 30,000 participants, showed higher plasma concentrations of DPA were associated with lower risk of heart attack. Similarly, another study showed people with evidence of CVD had lower levels of EPA, DHA and DPA as compared to healthy control subjects. Most importantly, the largest difference in fatty acid profiles was attributed to DPA, and only DPA showed an independent negative association with the disease after the adjustment for smoking habits.
Indeed, DPA has a good potential as a therapeutic compound. A large epidemiological trial showed dietary intake of DPA was significantly and inversely related to hardening of the arteries in Japanese adults. A separate study showed oral supplementation with purified DPA increased tissue concentrations of DPA, DHA and EPA in rats, while decreasing levels of arachidonic acida pro-inflammatory fatand restoring a healthy, critical balance of omega-3s to omega-6s.
Other studies examined the role of DPA in neurological health. For instance, it was demonstrated that DPA concentrations in blood of schizophrenic patients were significantly lower than those in blood of individuals from a matched control group. A separate study showed DPA supplementation may restore age-related decline in cognitive functions in an animal model.
Besides the role of DPA in cardiovascular, neurological and cognitive health, the compound may serve as a biomarker for other diseases. Human studies indicated a range of other potential health benefits, namely that DPA was the only EFA to have a positive effect on the aggressiveness of prostate cancer; and that omega-3/DPA levels are shown to be lower for alcohol-exposed subjects as compared to control groups.
Numerous studies indicate insufficient levels of DPA in diets and blood circulation may serve as a predictor and indicator of a broad range of health conditions. In addition, existing evidence points to DPA as a distinct and powerful nutritional and therapeutic supplement.